Home - Products - Angiogenesis - PDE - 2,5-dichloro-4-(difluoromethoxy)-N,N-dimethylbenzene-1-sulfonamide

2,5-dichloro-4-(difluoromethoxy)-N,N-dimethylbenzene-1-sulfonamide

CAS No. 473477-26-8

2,5-dichloro-4-(difluoromethoxy)-N,N-dimethylbenzene-1-sulfonamide( —— )

Catalog No. M28427 CAS No. 473477-26-8

2,5-dichloro-4-(difluoromethoxy)-N,N-dimethylbenzene-1-sulfonamide is a PDE inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 104 In Stock
2MG 65 In Stock
5MG 100 In Stock
10MG 149 In Stock
25MG 256 In Stock
50MG 367 In Stock
100MG 524 In Stock
200MG 713 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2,5-dichloro-4-(difluoromethoxy)-N,N-dimethylbenzene-1-sulfonamide
  • Note
    Research use only, not for human use.
  • Brief Description
    2,5-dichloro-4-(difluoromethoxy)-N,N-dimethylbenzene-1-sulfonamide is a PDE inhibitor.
  • Description
    2,5-dichloro-4-(difluoromethoxy)-N,N-dimethylbenzene-1-sulfonamide is a PDE inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    HSP90
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    473477-26-8
  • Formula Weight
    320.13
  • Molecular Formula
    C9H9Cl2F2NO3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(C)S(=O)(=O)c1cc(Cl)c(OC(F)F)cc1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Park S, et al. The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells. Cell Death Discov. 2021;7(1):354.
molnova catalog
related products
  • OPC18750 HCl

    OPC18750 HCl is a potential phosphodiesterase inhibitor with positive inotropic effects that can be used to study asthma, cancer, diabetes, and psychiatric disorders.

  • PDE4B-IN-2

    PDE4B-IN-2 (A 33) is an orally active and selective PDE4B inhibitor with an IC50 of 15 nM. PDE4B-IN-2 inhibits PDE4D (IC50=1.7 μM).

  • Arofylline

    Arofylline is a PDE4 inhibitor and can be used for asthma studies.